Although CES1 has been implicated in hepatic steatosis [37], a recent study has shown that CES1 may have potential as a biomarker to distinguish hepatocellular carcinoma (HCC) from cirrhosis [40]. The gene discussed is CES1; the disease is fatty liver disease.